Search

everythinglearnresearchcommunity

for

Search:↓

Lip feminization is important for transgender women, requiring personalized approaches and expert consultation for best results.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

More research is needed to improve lower body gender affirmation techniques.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Facial feminization surgery is safe and patients are satisfied, but more detailed research is needed.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

A woman developed male characteristics after using unregulated hormone therapy.